Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.

[1]  Thomas Wiegel,et al.  Guidelines on Prostate Cancer , 2013 .

[2]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[3]  A. Verbaeys,et al.  Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. , 2011, European journal of radiology.

[4]  R. Passariello,et al.  Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer. , 2011, Urologic oncology.

[5]  M. Özmen,et al.  The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings. , 2011, Diagnostic and interventional radiology.

[6]  M. Kattan,et al.  Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. , 2010, European urology.

[7]  C. McCulloch,et al.  Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. , 2010, Radiology.

[8]  C. Morash,et al.  Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer. , 2010, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[9]  M. Mclean,et al.  Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy. , 2010, International journal of radiation oncology, biology, physics.

[10]  J. Fütterer,et al.  Role of MRI in follow-up after focal therapy for prostate carcinoma. , 2010, AJR. American journal of roentgenology.

[11]  Piotr Kozlowski,et al.  Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy. , 2010, Magnetic resonance imaging.

[12]  M. Barkati,et al.  The use of magnetic resonance imaging for image‐guided brachytherapy , 2010, Journal of medical imaging and radiation oncology.

[13]  Roberto Passariello,et al.  Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.

[14]  Kazuro Sugimura,et al.  Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[15]  H. Hricak,et al.  Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. , 2010, Urology.

[16]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[17]  M. Menon,et al.  A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. , 2010, European urology.

[18]  Y. Yamashita,et al.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation , 2010, European Radiology.

[19]  H. Hricak,et al.  Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer , 2010, European Radiology.

[20]  A. Thompson,et al.  MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. , 2009, AJR. American journal of roentgenology.

[21]  Xavier Leroy,et al.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.

[22]  D. Beyersdorff,et al.  MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  H. Hricak,et al.  Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. , 2009, Radiology.

[24]  A. Evans,et al.  Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[25]  Mark Emberton,et al.  THE ROLE OF MAGNETIC RESONANCE IMAGING IN TARGETING PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES AND ELEVATED PROSTATE‐SPECIFIC ANTIGEN LEVELS , 2009, BJU international.

[26]  Jurgen J Fütterer,et al.  Imaging modalities for prostate cancer , 2009, Expert review of anticancer therapy.

[27]  Amita Shukla-Dave,et al.  The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer. , 2009, Clinical advances in hematology & oncology : H&O.

[28]  K. Pummer,et al.  Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the partin tables , 2009, Acta radiologica.

[29]  R. Passariello,et al.  Use of 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy (RRP): a potential diagnostic tool for optimal management of erectile dysfunction after RRP. , 2009, The journal of sexual medicine.

[30]  Amita Shukla-Dave,et al.  Functional magnetic resonance imaging in prostate cancer. , 2009, European urology.

[31]  Katarzyna J Macura,et al.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.

[32]  M. Harisinghani,et al.  Impact of preoperative endorectal MRI stage classification on neurovascular bundle sparing aggressiveness and the radical prostatectomy positive margin rate. , 2009, Urologic oncology.

[33]  I. Hsu,et al.  Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[34]  A. Labanaris,et al.  The role of conventional and functional endorectal magnetic resonance imaging in the decision of whether to preserve or resect the neurovascular bundles during radical retropubic prostatectomy , 2009, Scandinavian journal of urology and nephrology.

[35]  P. Gabriele,et al.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging , 2009, European Radiology.

[36]  K. Macura,et al.  Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping and Spectroscopy in Prostate Cancer , 2008, Topics in magnetic resonance imaging : TMRI.

[37]  M. Sumura,et al.  Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.

[38]  Derya Yakar,et al.  Magnetic Resonance-Guided Biopsy of the Prostate: Feasibility, Technique, and Clinical Applications , 2008, Topics in magnetic resonance imaging : TMRI.

[39]  Thomas Hambrock,et al.  Diffusion and perfusion MR imaging of the prostate. , 2008, Magnetic resonance imaging clinics of North America.

[40]  Thomas Hambrock,et al.  Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility , 2008, Investigative radiology.

[41]  Yousef Mazaheri,et al.  MR imaging of the prostate in clinical practice , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[42]  V. Panebianco,et al.  Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging. , 2008, European urology.

[43]  Roberto Passariello,et al.  Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. , 2008, European urology.

[44]  Katarzyna J Macura,et al.  MR-guided biopsy of the prostate: an overview of techniques and a systematic review. , 2008, European urology.

[45]  Daniele Regge,et al.  Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high‐intensity focused ultrasound , 2008, BJU international.

[46]  D. Regge,et al.  Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. , 2008, Clinical radiology.

[47]  Kate McLeish,et al.  Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants. , 2008, International journal of radiation oncology, biology, physics.

[48]  O. Rouvière,et al.  Détection par IRM des récidives locales du cancer de prostate après traitement par ultrasons focalisés de haute intensité (HIFU) transrectaux : étude préliminaire , 2008 .

[49]  B. K. Park,et al.  MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. , 2008, AJR. American journal of roentgenology.

[50]  I. Floriani,et al.  Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. , 2008, AJR. American journal of roentgenology.

[51]  Masoom A Haider,et al.  Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[52]  J. Chapelon,et al.  [MR detection of local prostate cancer recurrence after transrectal high-intensity focused US treatment: preliminary results]. , 2008, Journal de radiologie.

[53]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.